A detailed history of Klp Kapitalforvaltning As transactions in Eli Lilly & CO stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 304,719 shares of LLY stock, worth $311 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares
304,719
Previous 304,019 0.23%
Holding current value
$311 Million
Previous $237 Million 1.9%
% of portfolio
0.95%
Previous 1.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

BUY
$625.65 - $812.69 $437,955 - $568,883
700 Added 0.23%
304,719 $233 Million
Q2 2025

Jul 23, 2025

BUY
$713.71 - $898.95 $7.14 Million - $8.99 Million
10,000 Added 3.4%
304,019 $237 Million
Q1 2025

May 06, 2025

BUY
$725.72 - $929.72 $3.7 Million - $4.74 Million
5,100 Added 1.77%
294,019 $243 Million
Q4 2024

Feb 11, 2025

BUY
$727.2 - $932.06 $210 Million - $269 Million
288,919 New
288,919 $223 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Klp Kapitalforvaltning As Portfolio

Follow Klp Kapitalforvaltning As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klp Kapitalforvaltning As, based on Form 13F filings with the SEC.

News

Stay updated on Klp Kapitalforvaltning As with notifications on news.